Y. Nasa et al., IMPAIRMENT OF CGMP-MEDIATED AND CAMP-MEDIATED VASORELAXATIONS IN RATSWITH CHRONIC HEART-FAILURE, American journal of physiology. Heart and circulatory physiology, 40(6), 1996, pp. 2228-2237
To elucidate pathophysiological alterations in vascular relaxation in
rats with chronic heart failure (CHF), guanosine 3',5'-cyclic monophos
phate (cGMP)- and adenosine 3',5'-cyclic monophosphate (cAMP)-mediated
vasorelaxations in pulmonary artery (PA) and thoracic aorta (TA) of r
ats were examined 12 wk after corollary artery ligation. Acetylcholine
(Ach)-induced relaxation was attenuated in endothelium-intact segment
s of both arteries, whereas sodium nitroprusside-induced relaxation wa
s attenuated only in endothelium-intact TA segments of rats with CHF.
Vasorelaxations elicited by isoproterenol and NKH-477, a water-soluble
forskolin analogue, were diminished mainly in PA segments of the CNF
rat. N-G-nitro-L-arginine methyl ester (L-NAME)-induced decrease in cG
MP level was less in endothelium-intact TA segments of the rat with CH
F (0.20 +/- 0.06 vs. 0.99 +/- 0.26 pmol/mg protein in control), sugges
ting that basal nitric oxide (NO) production is reduced in CHF. Treatm
ent with L-NAME attenuated the isoproterenol-induced relaxation only i
n endothelium-intact TA segments in control rats but not in CE-IF Fats
. The results suggest Chat both cGMP- and cAMP-mediated relaxations ar
e impaired in CHF, and a I eduction of NO synthesis? presumably in end
othelial cells, plays a significant role in pathophysiogical alteratio
ns in vessels of rats with CHF.